Stocktoria
BIOCRYST PHARMACEUTICALS INC BCRX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1994-03-04
BIOCRYST PHARMACEUTICALS INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 19,956,255 | $123.3M |
| TWO SIGMA INVESTMENTS, LP | 6,392,628 | $60.9M |
| CITADEL ADVISORS LLC | 1,214,946 | $11.6M |
| RENAISSANCE TECHNOLOGIES LLC | 776,990 | $7.4M |
| Bridgewater Associates, LP | 638,054 | $6.1M |
| AQR CAPITAL MANAGEMENT LLC | 440,141 | $4.2M |
| MILLENNIUM MANAGEMENT LLC | 317,721 | $3.0M |
| D. E. Shaw & Co., Inc. | 302,101 | $2.9M |
Source: SEC EDGAR filings · CIK 0000882796 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.